154 related articles for article (PubMed ID: 6794141)
21. Evaluation of bone-wax extract on the frequency of chromosomal aberrations in the bone marrow of Swiss mice.
Mohanan PV; Rathinam K
Vet Hum Toxicol; 1993 Aug; 35(4):297-8. PubMed ID: 8236745
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of somatic cell chromosomes in patients treated with antineoplastic agents].
Selezneva TG; Korman NP
Genetika; 1973 Dec; 9(12):112-8. PubMed ID: 4219930
[No Abstract] [Full Text] [Related]
23. [History and significance to giant cells caused by mitosis inhibition].
Marinone G; Baserga A
Minerva Med; 1975 Jul; 66(49):2367-77. PubMed ID: 1056511
[No Abstract] [Full Text] [Related]
24. [Changes in the nucleus of erythroblasts during therapy with cyclophosphamide].
Brichta G; Reimer EE
Wien Z Inn Med; 1966 Apr; 47(4):154-9. PubMed ID: 6005161
[No Abstract] [Full Text] [Related]
25. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
[TBL] [Abstract][Full Text] [Related]
26. The action of cytostatic agents on the chromosomes of human leukocytes in vitro (preliminary communication).
Hampel KE; Kober B; Rösch D; Gerhartz H; Meinig KH
Blood; 1966 Jun; 27(6):816-23. PubMed ID: 4223454
[No Abstract] [Full Text] [Related]
27. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
Berger J
Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
[TBL] [Abstract][Full Text] [Related]
28. [The blood-simulating properties of a recombinant colony-stimulating factor and glycyram during cytostatic myelosuppression].
Dygaĭ AM; Zhdanov VV; Masycheva VI; Minakova MIu; Romanov VP; Pustoshilova NM; Simanina EV; Agafonov VI; Gol'dberg ED
Eksp Klin Farmakol; 1999; 62(1):34-7. PubMed ID: 10198763
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic toxicity of vincristine.
Choudhury RC; Das B; Misra S; Jagdale MB
J Environ Pathol Toxicol Oncol; 2000; 19(4):347-55. PubMed ID: 11213016
[TBL] [Abstract][Full Text] [Related]
30. Caffeine enhancement of chromosomal aberrations induced by thiotepa in bone marrow cells of mice.
Hansson K
Hereditas; 1978; 89(1):129-31. PubMed ID: 100478
[No Abstract] [Full Text] [Related]
31. Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases.
Nifontova I; Svinareva D; Petrova T; Drize N
Acta Haematol; 2008; 119(2):98-103. PubMed ID: 18334847
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of the restorative processes in the bone marrow of animals during the administration of cytostatic preparations].
Gol'dberg DI; Gol'dberg ED; Karpova FV; Dalinger LM; Golubev IV; Antipov IG; Dedova LS; Koifman EK; Kraiushkina NP; Kim EA; Grimberg LG; Novitskiĭ VV; Makarov AS
Probl Gematol Pereliv Krovi; 1970 Apr; 15(4):45-51. PubMed ID: 5453831
[No Abstract] [Full Text] [Related]
33. Induction of micronuclei in bone marrow cells of mice treated with phenylbutazone.
Pentiah PR; Reddy PP; Reddi OS
Indian J Exp Biol; 1980 Aug; 18(8):869-71. PubMed ID: 7461742
[No Abstract] [Full Text] [Related]
34. [Study of bone marrow cellularity in selective testing of the anti-tumor action of cytostatic drugs. Determination of the optimum of selectivity].
Rosin S
Stud Cercet Med Interna; 1967; 8(1):89-96. PubMed ID: 6043548
[No Abstract] [Full Text] [Related]
35. [Effect of rubomycin in combination with some cytostatic preparations on formation of hemagglutinins in mice].
Shapovalova SP
Antibiotiki; 1969 Dec; 14(12):1101-4. PubMed ID: 4984363
[No Abstract] [Full Text] [Related]
36. [The effect of D-glucuronic acid on the regenerative processes of granulomonocytopoiesis in cytostatic-induced myelodepression].
Gol'dberg ED; Dygaĭ AM; Karpova GV; Simanina EV; Khlusov IA; Shakhov VP; Agafonov VI
Eksp Klin Farmakol; 1993; 56(6):25-8. PubMed ID: 8111290
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of x rays on stem cells and maturing erythroid cells with that of various cytotoxic agents.
Twentyman PR
Br J Radiol; 1970 Feb; 43(506):152. PubMed ID: 5424287
[No Abstract] [Full Text] [Related]
38. Activity of aniline in the mouse bone marrow micronucleus assay.
Ashby J; Vlachos DA; Tinwell H
Mutat Res; 1991 Jun; 263(2):115-7. PubMed ID: 2046703
[TBL] [Abstract][Full Text] [Related]
39. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
40. The action of chemotherapeutic agents at the cellular level and the effects of these agents on hematopoietic and lymphomatous tissue.
Bruce WR
Proc Can Cancer Conf; 1967; 7():53-64. PubMed ID: 6047866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
